chronic non-atrophic gastritis
Conditions
Interventions
Case series:Orally taking Liqinuanwei granule
Sponsors
Huiren Group
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnosis of chronic superficial gastritis and endoscopy or biopsy in patients diagnosed (within six months of endoscopy or pathology report issued by the hospital can be used as basis for the diagnosis, researchers archive copy; no diagnosis basis on a patient in need of endoscopy or pathology); 2. Meet TCM for disharmony and relying on cold syndrome; 3. aged 18 to 75 years old; 4. voluntary participation in clinical trials and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients combined atrophic gastritis, non-reflux esophagitis, duodenal inflammation, gastric, esophageal dysplasia or histological diagnosis of suspected malignant; 2. Patients suffered nausea and vomiting can not be excluded by acute gastroenteritis; 3. Patients suffered other severe disease, diabetes poorly controled (fasting plasma glucose >=7.0mmol/L or postprandial glucose >=11.1mmol/L), and the disease impact of living, such as cancer or AIDS; 4. Patients suffered abnormal liver function (ALT or AST more than 2 folds the upper limit of normal), renal dysfunction (Scr exceed the upper limit of normal); 5. Patients with allergies, such as two or more (including two kinds) drug or food allergies; known to be allergic to the ingredients of the drug; 6. The investigator estimate the patients with low possibility of enrollment or complicate that, such as frequent changes in the work place lead to lost easily to follow; 7. Prepared pregnancy or pregnant women (except to terminate the pregnancy), lactating women; 8. Patients with drug or alcohol dependence; 9. The patient is participating in other clinical trials; 10. Researchers do believe patients unfit to participate in clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main symptom scores;Pain VAS score;main symptoms disappear time;Main symptoms disappear rate; | — |
Countries
China
Contacts
Public ContactMEI Linghua
Outcome results
None listed